Navarro-Ocón, A.; Blaya-Cánovas, J.L.; López-Tejada, A.; Blancas, I.; Sánchez-MartÃn, R.M.; Garrido, M.J.; Griñán-Lisón, C.; Calahorra, J.; Cara, F.E.; Ruiz-Cabello, F.;
et al. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics 2022, 14, 505.
https://doi.org/10.3390/pharmaceutics14030505
AMA Style
Navarro-Ocón A, Blaya-Cánovas JL, López-Tejada A, Blancas I, Sánchez-MartÃn RM, Garrido MJ, Griñán-Lisón C, Calahorra J, Cara FE, Ruiz-Cabello F,
et al. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics. 2022; 14(3):505.
https://doi.org/10.3390/pharmaceutics14030505
Chicago/Turabian Style
Navarro-Ocón, Alba, Jose L. Blaya-Cánovas, Araceli López-Tejada, Isabel Blancas, Rosario M. Sánchez-MartÃn, MarÃa J. Garrido, Carmen Griñán-Lisón, Jesús Calahorra, Francisca E. Cara, Francisco Ruiz-Cabello,
and et al. 2022. "Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer" Pharmaceutics 14, no. 3: 505.
https://doi.org/10.3390/pharmaceutics14030505
APA Style
Navarro-Ocón, A., Blaya-Cánovas, J. L., López-Tejada, A., Blancas, I., Sánchez-MartÃn, R. M., Garrido, M. J., Griñán-Lisón, C., Calahorra, J., Cara, F. E., Ruiz-Cabello, F., Marchal, J. A., Aptsiauri, N., & Granados-Principal, S.
(2022). Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics, 14(3), 505.
https://doi.org/10.3390/pharmaceutics14030505
